International Patent: CD33-BLOCKING ANTIBODY, CD33-BLOCKING HUMANIZED ANTIBODY AND USE THEREOF

GENEVA, June 26 -- RENJI HOSPITAL, SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE filed a patent application (CN2025/138324) for “CD33-BLOCKING ANTIBODY, CD33-BLOCKING HUMANIZED ANTIBODY AND USE THEREOF”. With publication no. WO/2026/119012, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07K 16/28

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....